Sign Out
Treatment and prophylaxis of bleeding in haemophilia A patients with F VIII inhibitor.
Treatment and prophylaxis of bleeding in haemophilia B patients with FIX inhibitor.
Treatment and prophylaxis of bleeding in non haemophiliacs with acquired inhibitors to factors VIII, XI, XII.
In one case FEIBA was successfully used in patient with an inhibitor, suffering from von Willebrand's disease.
FEIBA was also used in combination with Factor VIII concentrate for a continual long term therapy to achieve a complete and permanent elimination of the F VIII inhibitor so as to allow for regular treatment with F VIII concentrate as in patients without inhibitor.
Continue with Google